Snyder Mark Howard 4
4 · HALOZYME THERAPEUTICS, INC. · Filed Feb 11, 2026
Research Summary
AI-generated summary of this filing
Halozyme (HALO) SVP Mark Snyder Receives 78,087-Share Awards
What Happened
Mark Snyder, SVP and Chief Legal Officer of Halozyme Therapeutics (HALO), received a package of equity awards on February 9, 2026 that totals 78,087 derivative shares. The filing shows five separate awards acquired at $0.00 (i.e., compensation grants, not market purchases): 18,730 (option-like award), 17,396 (time-based RSUs), 4,651 (PSUs tied to a 2023 grant), 7,808 (PSUs tied to a 2024 grant), and 29,502 (PSUs tied to a 2025 grant). These awards are subject to the vesting and performance/service conditions described below.
Key Details
- Transaction date: 2026-02-09; Form 4 filed 2026-02-11 (timely within the typical two-business-day window).
- Total awarded: 78,087 derivative shares; acquisition price reported as $0.00 (compensation grants).
- Breakdown and vesting notes:
- 18,730 — option-style award (F1): vests 1/4 on a specified date, then 1/48th monthly thereafter.
- 17,396 — time-based RSUs (F2): vests 1/4 on first anniversary, then 1/4 on each subsequent anniversary.
- 4,651 — performance stock units from 2/16/2023 (F3): performance determination made for period ending 12/31/2025; units remain subject to service vesting through the 3rd anniversary of the grant date.
- 7,808 — performance stock units from 2/23/2024 (F4): performance determination made for period ending 12/31/2025; units remain subject to service vesting through the 3rd anniversary of the grant date.
- 29,502 — performance stock units from 2/20/2025 (F5): performance determination made for period ending 12/31/2025; units remain subject to service vesting through the 3rd anniversary of the grant date.
- Shares owned after the transaction: not specified in the provided filing.
- No sale, open-market purchase, cashless exercise, tax withholding, or 10b5-1 plan is indicated in the reported transactions.
Context
These are compensation grants and/or performance-based units rather than open-market purchases or sales — they do not represent an immediate cash outflow or market transaction. Performance stock units (PSUs) listed were adjusted/credited based on performance measurement periods ending Dec 31, 2025 but still require continued service (and in some cases additional vesting conditions) before resulting in issued common shares. For retail investors: awards show how the company compensates executives but are not a direct bullish/bearish signal like an insider buy or sell in the market.
Insider Transaction Report
- Award
Option to Purchase Common Stock
[F1]2026-02-09+18,730→ 18,730 totalExercise: $80.48From: 2027-02-09Exp: 2036-02-09→ Common Stock (18,730 underlying) - Award
Restricted Stock Units
[F2]2026-02-09+17,396→ 17,396 totalExercise: $0.00From: 2027-02-09→ Common Stock (17,396 underlying) - Award
Performance Stock Units
[F3]2026-02-09+4,651→ 12,016 totalExercise: $0.00→ Common Stock (4,651 underlying) - Award
Performance Stock Units
[F4]2026-02-09+7,808→ 45,127 totalExercise: $0.00→ Common Stock (7,808 underlying) - Award
Performance Stock Units
[F5]2026-02-09+29,502→ 29,502 totalExercise: $0.00→ Common Stock (29,502 underlying)
Footnotes (5)
- [F1]This option vests one-fourth on such date and then 1/48th monthly thereafter.
- [F2]This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter.
- [F3]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 16, 2023 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.
- [F4]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 23, 2024 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.
- [F5]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 20, 2025 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.